Moneycontrol PRO
Upcoming Webinar:Innovate Your Future at India Inc. on the Move on August 26 and 27, 2021 at 10am, with Rockwell Automation
you are here: HomeNewsBusiness

Unichem Lab gets USFDA nod for hypertension drug

The company "has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for losartan potassium and hydrochlorothiazide tablets USP, 50mg/12.5mg, 100mg/12.5 mg and 100mg/25mg," Unichem Laboratories said in a filing to BSE.

July 25, 2017 / 02:58 PM IST
Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Drug firm Unichem Laboratories today said it has received approval from the US health regulator for losartan potassium and hydrochlorothiazide, used in treatment of hypertension and reduction in risk of strokes in patients with hypertension.

The company "has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for losartan potassium and hydrochlorothiazide tablets USP, 50mg/12.5mg, 100mg/12.5 mg and 100mg/25mg," Unichem Laboratories said in a filing to BSE.

The tablets are generic versions of Merck Sharp & Dohme Corporation.

The product will be commercialised from the company's Ghaziabad plant. Active Pharmaceutical Ingredient will also be made in-house at Pithampur/Roha API Plant, Unichem Laboratories said.

Shares of Unichem Laboratories were trading at Rs 278 in afternoon trade on BSE, up 2.32 per cent from previous close. PTI SVK .
first published: Jul 25, 2017 01:31 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark